JP2017511138A5 - - Google Patents

Info

Publication number

JP2017511138A5

JP2017511138A5 JP2016560431A JP2016560431A JP2017511138A5 JP 2017511138 A5 JP2017511138 A5 JP 2017511138A5 JP 2016560431 A JP2016560431 A JP 2016560431A JP 2016560431 A JP2016560431 A JP 2016560431A JP 2017511138 A5 JP2017511138 A5 JP 2017511138A5

Authority

JP

Japan

Prior art keywords

loop region

sites

disease

subject

site

Prior art date

2015-03-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108091029430 CpG site Proteins 0.000 claims description 55
• 101150015830 nd1 gene Proteins 0.000 claims description 53
• 230000011987 methylation Effects 0.000 claims description 46
• 238000007069 methylation reaction Methods 0.000 claims description 46
• 238000000034 method Methods 0.000 claims description 38
• 108020005196 Mitochondrial DNA Proteins 0.000 claims description 27
• 208000024827 Alzheimer disease Diseases 0.000 claims description 26
• 208000018737 Parkinson disease Diseases 0.000 claims description 18
• 239000002773 nucleotide Substances 0.000 claims description 17
• 125000003729 nucleotide group Chemical group 0.000 claims description 17
• 230000006607 hypermethylation Effects 0.000 claims description 15
• 108020004707 nucleic acids Proteins 0.000 claims description 15
• 102000039446 nucleic acids Human genes 0.000 claims description 15
• 150000007523 nucleic acids Chemical class 0.000 claims description 15
• 238000000338 in vitro Methods 0.000 claims description 14
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 11
• 201000010099 disease Diseases 0.000 claims description 11
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
• 230000004770 neurodegeneration Effects 0.000 claims description 9
• 208000015122 neurodegenerative disease Diseases 0.000 claims description 9
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 8
• 238000011282 treatment Methods 0.000 claims description 8
• 108091034117 Oligonucleotide Proteins 0.000 claims description 5
• 229940104302 cytosine Drugs 0.000 claims description 5
• 238000001514 detection method Methods 0.000 claims description 4
• 238000011321 prophylaxis Methods 0.000 claims description 4
• 229940035893 uracil Drugs 0.000 claims description 4
• 238000003745 diagnosis Methods 0.000 claims description 3
• 230000001419 dependent effect Effects 0.000 claims description 2
• 238000009396 hybridization Methods 0.000 claims description 2
• 238000012544 monitoring process Methods 0.000 claims description 2
• 108091033319 polynucleotide Proteins 0.000 claims description 2
• 102000040430 polynucleotide Human genes 0.000 claims description 2
• 239000002157 polynucleotide Substances 0.000 claims description 2
• 238000012175 pyrosequencing Methods 0.000 claims 2
• 239000007787 solid Substances 0.000 claims 2
• 210000001519 tissue Anatomy 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 238000007450 ChIP-chip Methods 0.000 claims 1
• 208000031124 Dementia Alzheimer type Diseases 0.000 claims 1
• 238000003556 assay Methods 0.000 claims 1
• 239000013060 biological fluid Substances 0.000 claims 1
• 238000001574 biopsy Methods 0.000 claims 1
• 238000001369 bisulfite sequencing Methods 0.000 claims 1
• 210000005013 brain tissue Anatomy 0.000 claims 1
• 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
• 238000006243 chemical reaction Methods 0.000 claims 1
• 238000007855 methylation-specific PCR Methods 0.000 claims 1
• 210000005259 peripheral blood Anatomy 0.000 claims 1
• 239000011886 peripheral blood Substances 0.000 claims 1
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 claims 1
• 230000007067 DNA methylation Effects 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1